Skip to main content

Viral Infections and Antiviral Therapies

  • 1st Edition - November 10, 2022
  • Latest edition
  • Editors: Amal Kumar Dhara, Amit Kumar Nayak
  • Language: English

Viral Infections and Antiviral Therapies provides comprehensive coverage of viral infections and their transmission. Coverage includes antiviral agents, therapeutics, their mechan… Read more

Data Mining & ML

Unlock the cutting edge

Up to 20% on trusted resources. Build expertise with data mining, ML methods.

Description

Viral Infections and Antiviral Therapies provides comprehensive coverage of viral infections and their transmission. Coverage includes antiviral agents, therapeutics, their mechanisms and treatment strategies. The book is organized into four sections, including an introduction to antiviral therapies, viral infections and their transmission, antiviral agents and therapeutics, and a market overview and future developments. The chapters in each section of the book discuss various key topics that are contributed to by an international group of leading experts.

Key features

  • Covers emerging and sexually transmitted viruses, including mode of transmission and pathophysiology of viral infections
  • Describes antiviral agents and therapeutics for viruses such as rotaviruses, enteroviruses and coronaviruses
  • Discusses strategies for the delivery of antiviral agents and vaccinations

Readership

Researchers and Scientists in virology and pharmaceutical sciences; Biomedical and pharmaceutical academia and professionals in the industries; Regulatory scientists in medicine, biomedicine, pharmaceutics, biotechnology, biology, microbiology; Graduate students and post docs with relevant background in virology and pharmacology

Table of contents

Preface
Amal Kumar Dhara

Section I: Introduction

1. Introduction to antiviral therapy
Amal Kumar Dhara

Section II: Viral infections and transmission

2. Emerging viral diseases
Agniva Majumdar and Pradip Kumar Jana

3. Evolution and transmission of viruses
Shalini Upadhyay

4. Mode of viral infections and transmissions
Sora Yasri

5. Transmission and Intervention Dynamics of SARS-CoV-2
Michael K. Danquah

6. Sexually transmitted viral infections
A Dasgupta

7. Testing of viral infections
Shalini Upadhyay

8. Electron microscopic methods for virus diagnosis
Nadeesh Adassooriya

Section III: Antiviral agents and therapeutics

9. Virotherapy
Sathiamoorthi Thangavelu, Palanivel Velmurugan, Saikishore Ramanathan and Ranjithkumar Dhandapani

10. Challenges in designing antiviral agents
Edeildo Ferreira da Silva Junior

11. Anti-influenza agents
Ashwini Chauhan and Sambuddha Chakraborty

12. Anti-herpes virus agents
Keshab Mondal

13. Antiretroviral Therapies
Debjit Chakraborty

14. Rotavirus and anti-rotaviral agents: Trends and advances
Ujjwal De

15. Current therapeutic strategies and novel antiviral compounds for the treatment of non-polio enteroviruses
Regina Sharmila Dass

16. Antiviral agents against flaviviruses
Edeildo Ferreira da Silva Junior

17. Pathophysiology of HIV and strategies to eliminate AIDS as a public health threat
Omar Sued and Tomas Grosso

18. Herbal drugs to combat viruses
Benil PB, Rajakrishnan Rajagopal, Ahmed Alfarhan and Jacob Thomas

19. Strategies for delivery of antiviral agents
Blessing Atim Aderibigbe

20. Nanovesicles for delivery of antiviral agents
Ibrahim M. El-Sherbiny

21. Antiviral biomaterials
Sandhya Khunger

22. Antiviral biomolecules from marine inhabitantsBalasubramanian
Vellaisamy, Ishwarya Ayyanar, Subidsha Suyambu Krishnan, Akila Ravindran and Sunandha Jeeva Bharathi

23. Plant polysaccharides as antiviral agents
Amit Kumar Nayak

24. Antiviral peptides against dengue virus
Chit-Laa Poh and Michelle Felicia Lee

25. mRNA vaccines for COVID-19
Anamika Sengupta

26. Immunotherapy as an emerging and promising tool against viral infections
Prof. Vahid Reza Askari

27. Role of nutraceuticals as immunomodulators to combat viruses
Benil PB, Vrenda Roy, Rajakrishnan Rajagopal and Ahmed Alfarhan

Section IV: Others

28. In vitro and in vivo approaches for evaluating antiviral efficacy
Ram Gopal Nitharwal

29. Clinical trials and regulatory considerations of antiviral agents
Samir Bhargava, Dr. Bhavna, Amal Kumar Dhara, Neeraj Sethiya, Jagannath Sahoo, Havagiray Chitme, Mayuri Gupta, Navraj Upreti and Yusra Ahmad

30. Future perspectives of antiviral therapy
Debesh Chandra Bhattacharya

Product details

  • Edition: 1
  • Latest edition
  • Published: November 11, 2022
  • Language: English

About the editors

AD

Amal Kumar Dhara

Dr. Amal Kumar Dhara has over 27 years of teaching and research experience in Pharmacology and Toxicology, with expertise in neuropharmacology, anti-inflammatory, antiulcer, and free radical scavenging activities of Indian medicinal plants. He earned his PhD in Pharmaceutical Sciences from Jadavpur University, Kolkata, West Bengal, India. Dr. Dhara currently serves as Head of the Department (Pharmacy) at Contai Polytechnic, Government of West Bengal, India. He has previously worked as a Production Executive at M/S Deys Medical Stores Mfg (UP) Ltd., Uttar Pradesh, for over three years. Dr. Dhara has authored more than ten research and review papers in reputed journals, along with fifteen book chapters and five books. He has presented his work at national and international conferences and is a life member of the Indian Pharmaceutical Association and Indian Pharmacological Society, as well as a registered pharmacist.
Affiliations and expertise
Department of Pharmacy, Contai Polytechnic, Government of West Bengal, Contai, Purba Medinipur, West Bengal, India

AN

Amit Kumar Nayak

Amit Kumar Nayak (M. Pharm, Ph.D) is currently working as Professor at School of Pharmaceutical Sciences,Siksha ‘O' Anusandhan (Deemed to be University), Odisha, India. He has earned his PhD from IFTM University, Moradabad, Uttar Pradesh, India. He has over 14 years of research experiences in the field of pharmaceutics, especially in the development and characterization of novel biopolymeric and nanostructured drug delivery systems. Till date, he has authored more than 138 research and review publications in various high-impact peer-reviewed journals and 135 book chapters. He has edited/authored 23 international books to his credit. Dr. Nayak has presented his research work at several conferences. He has received University Foundation Day Research Award, 2019 and 2022 by Biju Patnaik University of Technology, Odisha. Dr. Nayak is a life member of the Association of Pharmaceutical Teachers of India (APTI) and a registered pharmacist.

Affiliations and expertise
Professor, Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India

View book on ScienceDirect

Read Viral Infections and Antiviral Therapies on ScienceDirect